R-Tech Ueno has announced the end of a Phase III clinical study with Rescula (unoprostone) ophthalmic solution for the treatment...
Mallinckrodt plc a leading global specialty pharmaceutical company, and Sucampo Pharmaceuticals, Inc., a global biopharmaceutical company, announced that they have...